yl23411永利(中国)有限公司-搜狗百科
中文版
|
简体
|
繁體版
English
Home
About GUCON
Products Centre
Order Info
Distributor Centre
Scientific Info
Technical Info
Join GUCON
Feedback
Contact GUCON
} }); });
中文版
|
简体
|
繁體版
English
Home
About GUCON
Product Center
Bone Markers
Respiratory Assay
Gastrology Assay
Cardiovascular Assay
Drug Level Assay
Lab Consumables
Antibody & Antigen
Food Nutrition
Hormone Assay
Order Info
Distributor Centre
Scientific Info
Technical Information
IFU
Brochure
Publication
Feedback
Join GUCON
Contact GUCON
GUCON News
technical information
IFU
Brochure
Publication
CURRENT LOCATION:
Home
yl23411永利
>
Technical Info
>
2022.03.14
Early drug and anti-infliximab antibody levels for predictio
2022.03.14
Higher Adalimumab Drug Levels During Maintenance Therapy for
2021.08.20
Infliximab
2018.01.15
BI-20433_Periostin_ELISA_IFU
共
1
页
4
条记录
Home
|
About GUCON
|
GUCON News
|
Products Centre
|
Distributor Centre
|
Contact GUCON
|
Address:Rm. 405-410, 4th Floor, Bldg. B4, No. 11, Kaiyuan Avenue, Science City, Guangzhou Hi-tech Industrial Zone, Huangpu District, Guangzhou, Guangdong, China
Zip code:510530 Tel: 020-32293178 / 020-32293176
Fax: 020-32293177 E-mail:sales@gucon.com Website: www.gucon.com
Sales Department:
Tel:020-32293178 020-32293176
mobile phone: 18927505895
E-mail:sales@gucon.com or market@gucon.com
Technical support department:
Tel:020-32293178
E-mail:service@gucon.com
Tel
QQ
address
home